Comparing Australian orthopaedic surgeons’ reported use of thromboprophylaxis following arthroplasty in 2012 and 2017
Abstract Background It is generally accepted that all arthroplasty patients should receive venous thromboembolism (VTE) and bleeding risk assessments, and that postoperative thromboprophylaxis be routinely prescribed where appropriate. Guideline recommendations regarding what to prescribe, however,...
Main Authors: | Corinne Mirkazemi, Luke R. Bereznicki, Gregory M. Peterson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12891-019-2409-3 |
Similar Items
-
Chinese Survey on Enhanced Recovery after Surgery and Thromboprophylaxis Following Arthroplasty
by: Xi‐sheng Weng, et al.
Published: (2020-06-01) -
Safety and efficacy of a new thromboprophylaxis regiment for total knee and total hip replacement: a retrospective cohort study in 265 patients
by: Mohammad Amre Fallaha, et al.
Published: (2018-08-01) -
What’s new in VTE risk and prevention in orthopedic surgery
by: Susan R. Kahn, et al.
Published: (2020-03-01) -
Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis
by: Cheng-Ta Wu, et al.
Published: (2018-07-01) -
Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials
by: Rosencher Nadia, et al.
Published: (2012-06-01)